The peroxisomal proliferator–activated receptor-gamma agonist rosiglitazone appears to reduce the risk of in-stent restenosis in atherosclerotic coronary arteries, a new study shows. […]
We present a case of acute type A aortic dissection in a patient with COVID-19 to highlight the clinical implications of a true emergent procedure during the COVID-19 outbreak.
